HIMS & HERS HEALTH INC (HIMS) Stock News
NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock - Currency: USD
HIMS Latest News, Press Relases and Analysis
HIMS & HERS HEALTH INC (NYSE:HIMS) – A High-Growth Stock Meeting Minervini’s Trend Template
HIMS & HERS HEALTH (NYSE:HIMS) meets Minervini’s Trend Template with strong technicals and explosive earnings growth, making it a high-growth momentum candidate.
Market Monitor News May 12 ( NRG Energy, Amazon, Meta Platforms UP - CVS Health DOWN)
Wall Street Surges on Temporary Trade Truce Between US and China
Why Hims & Hers Health (HIMS) Stock Is Falling Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.3% in the afternoon session after Cigna Group's Evernorth division introduced a monthly $200 price cap for weight-loss medications such as Wegovy and Zepbound, a move that could significantly disrupt pricing in the weight loss drug market.
Hims & Hers Introduces 6-Month Wegovy® New Customer Offer
Hims & Hers Stock Drops After Evernorth Announces Cheaper Pricing For Weight-Loss Drugs: Retail’s Dull
Truist noted on Thursday that the $200/month price point is "highly attractive compared to other price points in the market," including Hims & Hers' compounded Semaglutide, Wegovy, and Liraglutide subscription programs.
Hims & Hers Health Stock Is Tumbling Thursday: What's Happening?
Hims & Hers Health, Inc (NYSE:HIMS) is facing heavy selling pressure Thursday morning as the U.S. Food and Drug Administration's (FDA) ban of compounded drugs with semaglutide takes effect.
Nvidia, Tesla lead over $250 billion in short seller losses during massive market rally
Investors betting against stocks have lost more than $250 billion during the market's trade-induced rally.
Up 157% in 2025, Is It Too Late to Buy Hims & Hers Stock?
Envista, NeoGenomics, Acadia Healthcare, Astrana Health, and Hims & Hers Health Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the major pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that could worsen the already wide US fiscal deficit.
MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio
Merit Medical aims to provide an additional effective solution that complements a wide range of percutaneous procedures, including interventional radiology and cardiology.
AST Business Growth & Strategic Acquisitions Support STERIS Stock
STE frequently engages in strategic acquisitions and joint ventures to optimize its portfolio of businesses.
5 Single-Stock ETFs That Doubled in a Month
We have highlighted five single-stock ETFs that have doubled over the past month amid a historic Wall Street comeback.
Are Medical Stocks Lagging DBV Technologies (DBVT) This Year?
Here is how DBV Technologies S.A. (DBVT) and Hims & Hers Health, Inc. (HIMS) have performed compared to their sector so far this year.
Mentions: DBVT
Why Hims & Hers Health, Inc. (HIMS) Skyrocketed on Friday
We recently published a list of 10 Surprising Stocks That Skyrocketed Today. In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against other Friday’s top performers. The stock market finished the trading week in the green territory as investors looked past the series of mixed […]
Hims & Hers Stock Chart Points to Strong Bullish Continuation
Hims & Hers Health, Inc. stock price action shows strongly bullish signs in May and could be ready to hit new highs before the 2nd half starts.
Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software
ILMN's latest software features easy-to-use oncology apps, enhanced multiomics pipelines and AWS F2 support, enabling faster turnaround times.
ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues
Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.
Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs
Per REFLECT studies, ABT's Libre technology is the first CGM linked to fewer hospitalizations for heart complications in people with diabetes.
Here's Why You Should Add Hims & Hers Stock to Your Portfolio Now
Hims & Hers leads with AI-powered, personalized health plans (over 70% of new users opt in). Recurring revenues surge as tailored care drives loyalty.
Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now?
HIMS is expanding its health and wellness products and services and increasing its focus on AI to solidify its footing. However, macro challenges may hurt performance.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
Omnicell's New Perioperative Clinic Setting Products May Boost Stock
OMCL unveils new offerings for the perioperative and clinic setting.
Stock market today: Nasdaq notches 6th day of gains as Nvidia, chips lead tech rally
US stocks floated higher after the S&P 500 erased its losses for 2025 the previous day.
Stock market today: Nasdaq edges higher as Nvidia, AMD lead chip gains
US stocks floated higher after the S&P 500 erased its losses for 2025 the previous day.
Hims & Hers Health, Inc. (HIMS) is a Great Momentum Stock: Should You Buy?
Does Hims & Hers Health, Inc. (HIMS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Top Health & Fitness Stocks to Buy for the Wellness Boom
The health and fitness boom is fueling demand for gyms, nutrition, and wellness services. Stocks like SFM, HIMS and DXCM are well-positioned to benefit.
Is First Trust Mid Cap Growth AlphaDEX ETF (FNY) a Strong ETF Right Now?
Smart Beta ETF report for FNY
Hims & Hers Stock Sparks Retail Trader Frenzy After CEO Announces 'Largest Raise Yet' Of $1B
CEO Andrew Dudum said it was “more than double what we set out for,” thanks to strong investor demand.
Why Hims & Hers Health, Inc. (HIMS) Skyrocketed On Tuesday
We recently published a list of 10 Firms Crushing the Market. In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against other firms that are crushing the market. The stock market finished the trading day on a mixed note, as investors continued to digest April inflation […]
The Zacks Analyst Blog Highlights Sprouts Farmers Market, DexCom, Hims & Hers Health, United Natural Foods and GoodRx
Sprouts Farmers Market, DexCom, Hims & Hers Health, United Natural Foods and GoodRx are included in this Analyst Blog.
Unlocking the Growth Potential of HIMS & HERS HEALTH INC (NYSE:HIMS).
A fundamental analysis of (NYSE:HIMS): HIMS & HERS HEALTH INC (NYSE:HIMS) showing high EPS and FCF growth while beating expectations
Market Monitor May 7 ( Hims & Hers Health, Upwork UP - Palantir, Monderna DOWN)
Wall Street Retreats as Pharma Stocks Tumble and Trade Uncertainty Lingers
Which stocks are most active on Tuesday?
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session.